Arthur F. Ryan, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1 shares at $1100.03 ($1K) on 2024-08-01, disclosed to the SEC on 2024-08-05.
Scheduled sale ($1k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2026-04-03 | $78K | — | Filing → |
| REGN | SELL | 2026-03-03 | $79K | — | Filing → |
| REGN | SELL | 2026-02-11 | $78K | — | Filing → |